Zymeworks Inc.
ZYME
$22.88
-$0.35-1.51%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.52M | 27.61M | 48.73M | 27.11M | 31.03M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.52M | 27.61M | 48.73M | 27.11M | 31.03M |
| Cost of Revenue | 31.24M | 35.58M | 34.45M | 35.74M | 37.06M |
| Gross Profit | -28.72M | -7.96M | 14.28M | -8.63M | -6.03M |
| SG&A Expenses | 15.43M | 14.15M | 14.95M | 16.99M | 16.19M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 46.67M | 49.72M | 49.40M | 52.72M | 53.25M |
| Operating Income | -44.15M | -22.11M | -674.00K | -25.61M | -22.22M |
| Income Before Tax | -41.48M | -18.27M | 2.13M | -22.14M | -17.79M |
| Income Tax Expenses | -270.00K | 1.34M | -186.00K | 496.00K | 5.72M |
| Earnings from Continuing Operations | -41.21M | -19.60M | 2.32M | -22.64M | -23.51M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -41.21M | -19.60M | 2.32M | -22.64M | -23.51M |
| EBIT | -44.15M | -22.11M | -674.00K | -25.61M | -22.22M |
| EBITDA | -43.07M | -20.56M | 1.82M | -23.02M | -19.22M |
| EPS Basic | -0.55 | -0.26 | 0.03 | -0.30 | -0.31 |
| Normalized Basic EPS | -0.34 | -0.15 | 0.02 | -0.18 | -0.15 |
| EPS Diluted | -0.55 | -0.26 | 0.03 | -0.30 | -0.32 |
| Normalized Diluted EPS | -0.34 | -0.15 | 0.02 | -0.18 | -0.15 |
| Average Basic Shares Outstanding | 75.34M | 75.77M | 75.34M | 75.17M | 74.66M |
| Average Diluted Shares Outstanding | 75.34M | 75.78M | 77.38M | 75.23M | 74.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |